Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

about

Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib

P2860

Q58612405-82121606-AACE-4A39-AA7C-69C1D5E508D4

P2860

Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

Item

http://www.wikidata.org/entity/Q47102326

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Milder degenerative effects of ...... nk to clinical adverse events.

@en

Milder degenerative effects of ...... nk to clinical adverse events.

@nl

type

Item

label

Milder degenerative effects of ...... nk to clinical adverse events.

@en

Milder degenerative effects of ...... nk to clinical adverse events.

@nl

prefLabel

Milder degenerative effects of ...... nk to clinical adverse events.

@en

Milder degenerative effects of ...... nk to clinical adverse events.

@nl

P1476

Milder degenerative effects of ...... nk to clinical adverse events.

@en

P2093

Alexios-Leandros Skaltsounis

http://www.w3.org/2001/XMLSchema#string

Efstathios Kastritis

http://www.w3.org/2001/XMLSchema#string

Eleni N Tsakiri

http://www.w3.org/2001/XMLSchema#string

Eleni-Dimitra Papanagnou

http://www.w3.org/2001/XMLSchema#string

Evangelos Terpos

http://www.w3.org/2001/XMLSchema#string

Herman S Overkleeft

http://www.w3.org/2001/XMLSchema#string

Ioannis P Trougakos

http://www.w3.org/2001/XMLSchema#string

Maria Halabalaki

http://www.w3.org/2001/XMLSchema#string

Tina Bagratuni

http://www.w3.org/2001/XMLSchema#string

Vincent Brieudes

http://www.w3.org/2001/XMLSchema#string

P2860

Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease

Autophagy in the Pathogenesis of Disease

Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation.

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing.

Stress-activated cap'n'collar transcription factors in aging and human disease

Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging.

Bacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseases

Drug screening using model systems: some basics

Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report.

Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells.

P2888

s41598-017-17596-4

P304

17802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-17596-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Luca Scorrano

Meletios A. Dimopoulos

Bogdan I Florea

P577

2017-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29259189

http://www.w3.org/2001/XMLSchema#string

P921

Drosophila

P932

5736585

http://www.w3.org/2001/XMLSchema#string

Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

about

P2860

P2860

Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932